GAMMA Investing’s Third Harmonic Bio THRD Stock Holding History

GAMMA Investing’s Portfolio THRD Stock Details THRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.46K	Hold	458	–	–	﹤0.01%	3693
2026 Q1	$2.46K	Hold	458	–	–	﹤0.01%	3597
2025 Q4	$2.46K	Hold	458	–	–	﹤0.01%	3542
2025 Q3	$2.46K	Buy	458 +353	+336%	+$1.92K	﹤0.01%	3399
2025 Q2	$570	Buy	+105	New	+$524	﹤0.01%	3616
2025 Q1	–	Sell	-97	Closed	-$998	–	3882
2024 Q4	$998	Sell	97 -23	-19%	-$287	﹤0.01%	3422
2024 Q3	$1.63K	Buy	120 +7	+6%	+$87	﹤0.01%	3130
2024 Q2	$1.47K	Buy	113 +16	+16%	+$198	﹤0.01%	2969
2024 Q1	$916	Buy	97 +20	+26%	+$194	﹤0.01%	2961
2023 Q4	$668	Buy	+77	New	+$610	﹤0.01%	2898

GAMMA Investing's THRD Position: Q2 2026 in Review

GAMMA Investing held its Third Harmonic Bio (THRD) position steady in Q2 2026 at 458 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3693.

GAMMA Investing first reported a position in THRD in Q4 2023 and has held it in 10 quarters since. 2 funds tracked by Wall St. Rank hold THRD as of Q2 2026.

GAMMA Investing held 458 shares of Third Harmonic Bio worth $2.46K as of Q2 2026.
GAMMA Investing left its Third Harmonic Bio share count unchanged in Q2 2026.
Third Harmonic Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3693 holding.
GAMMA Investing first reported a position in Third Harmonic Bio in Q4 2023 and has held it in 10 quarters since.
2 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.